# P-01: Predictive Occlusion-Isolation Controller
## Buyer Technical Briefing (R279 — HONEST UPDATE)

### What changed since R278

**The R278 claim ("7-9x improvement") was overstated.** It was true only against the weakest baseline (single-path, no control). Against the strongest published baseline (predictive closed-loop valve modulation — US20210338992A1 + 2023 ML study), our isolation mechanism does NOT add value on time-to-failure and is FRAGILE under sensor noise.

We are telling you this upfront because credibility matters more than a sales pitch.

### What the V1.2 A/B/C/D/E comparison shows

| Arm | What it is | Peak ICP | Time to failure | Under 3x noise |
|-----|-----------|----------|-----------------|----------------|
| A (conventional) | 1 segment, no control | 59 mmHg | 1.3h | 1.1h (peak 133!) |
| B (reactive) | 4 segments, isolate on actual failure | 37 mmHg | 0.8h | 0.0h |
| C (P-01) | 4 segments, predictive isolation | 22 mmHg | 7.7h | 3.5h |
| **D (strongest baseline)** | 4 segments, predictive closed-loop, NO isolation | 30 mmHg | **8.9h** | **8.9h** |
| E (oracle) | Perfect knowledge, optimal isolation | 20 mmHg | 7.7h | 7.7h |

### The honest finding

**C (our approach) does NOT outperform D (existing published approach).**

- On time-to-failure: D wins by 14% (8.9h vs 7.7h) under normal conditions
- Under sensor noise: D wins by 61% (8.9h vs 3.5h) — C's predictor fires false positives, causing premature isolation
- On peak ICP: C wins by 8 mmHg under low noise (22 vs 30), but under noise they're equal (~29)

The isolation mechanism is only beneficial for peak ICP under ideal sensing conditions. Under realistic noise, it's actively harmful.

### What this means for you (the buyer)

1. **If you already have a closed-loop shunt program** (like US20210338992A1), P-01's isolation mechanism does NOT add value beyond what you likely already have.

2. **If you do NOT have a closed-loop program**, Arm D (predictive closed-loop modulation) is the approach to pursue — not Arm C (predictive isolation). We can share the D controller design.

3. **The multi-segment hardware concept** (4 parallel drainage paths) still has value — it enables redundancy and load distribution. But the control law should be D-style (soft modulation), not C-style (hard isolation).

4. **The one potentially valuable negative result**: reactive redundancy (B) is WORSE than single-path (A). This means simply adding redundant catheters without intelligent control is harmful. This is a non-obvious finding that could inform your product strategy.

### What we are NOT selling

- We are NOT selling a "7-9x improvement" — that was an overclaim against a weak baseline
- We are NOT selling a "prevents shunt failure" system — the system breaks at ~8h under 2-segment failure
- We are NOT selling "current standard of care" comparison — 59 mmHg is our model's baseline, not clinical data
- We are NOT selling IP clearance — US20210338992A1 is adjacent prior art that your counsel must assess

### What we ARE offering

- An honest, reproducible simulator that you can run today (Python, no dependencies, 25 scenarios in 30 seconds)
- The A/B/C/D/E comparison code so you can verify our finding that D > C
- The negative result that B < A (reactive redundancy is harmful)
- A technology-transfer package for Arm D (predictive closed-loop multi-segment controller) if you want to pursue that direction
- A collaborative conversation about whether the isolation mechanism has value for infection control or maintenance (untested hypothesis)

### Pricing reality

The R278 indicative price was $500K. R279 honest reassessment: if P-01 is reformulated as Arm D (close to existing published art), the value is lower. If the isolation mechanism can be repositioned for infection control (untested), value is uncertain. We are not revising the price until the strategic direction is decided.

### What we ask of you

1. Run the V1.2 simulator: `python 08_ABCDE_comparison.py` (30 minutes)
2. Verify that D > C on time-to-failure (our key finding)
3. Tell us: does the B < A finding (reactive redundancy is harmful) change your product strategy?
4. Tell us: do you see value in the isolation mechanism for infection control or maintenance?
5. If you want the D controller design for your own program, we can discuss a technology-transfer package

### Contact
Package owner: [your contact]
Repository: github.com/prateekm1007/discovery-evidence-fabric
Commit: R279 (this round)
